about
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...
Read More
12.28
0.10
(0.82%)
593.6K
XNAS Volume
XNAS 16 Mar, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..